Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.1 USD | +1.89% | -6.41% | -6.54% |
Mar. 12 | Illumina Investor Carl Icahn Withdraws Bid for Board Seat, Continues Legal Battle Over Grail Acquisition | MT |
Mar. 12 | Exclusive-Icahn drops Illumina board challenge threat, sources say | RE |
Evolution of the average Target Price on Illumina, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Illumina, Inc.
UBS | |
TD Cowen | |
Barclays | |
Citigroup | |
Stifel Nicolaus | |
Baird | |
RBC Capital Markets | |
Scotiabank | |
Stephens Inc. | |
BofA Securities | |
Canaccord Genuity | |
Bernstein | |
Piper Sandler | |
HSBC | |
JPMorgan Chase | |
Evercore ISI | |
Credit Suisse | |
SVB Securities LLC | |
Argus | |
OTR Global | |
Morgan Stanley | |
Cowen | |
SVB Leerink | |
BTIG | |
Wells Fargo Securities | |
Atlantic Equities |
EPS Revisions
- Stock
- Equities
- Stock Illumina, Inc. - Nasdaq
- Consensus Illumina, Inc.